News U.S. Death Rate Declined in 2022, COVID Deaths Fell by Almost Half May 4, 2023 Read More » Radiologists’ Group Pushes for Breast Cancer Risk ‘Assessment’ by Age 25 May 4, 2023 Read More » SD Biosensor, Inc. Requests Discontinuation of Use and Disposal of Specific Pilot™ COVID-19 At Home Tests in the United States Due to Microbial Contamination in the Liquid Buffer Solution May 4, 2023 Read More » Arexvy May 3, 2023 Read More » Cedars-Sinai Develops AI to Predict Adverse Cardiac Events May 2, 2023 Read More » Lumryz May 1, 2023 Read More » Uzedy extended-release injectable approved by FDA for treatment of Schizophrenia April 28, 2023 Read More » FDA Approves Abilify Asimtufii® (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults April 28, 2023 Read More » Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error April 27, 2023 Read More » Page1 Page2 Page3 … Page30 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required) Email(Required) Comment(Required) Company Name(Required) CAPTCHA
SD Biosensor, Inc. Requests Discontinuation of Use and Disposal of Specific Pilot™ COVID-19 At Home Tests in the United States Due to Microbial Contamination in the Liquid Buffer Solution May 4, 2023 Read More »
Uzedy extended-release injectable approved by FDA for treatment of Schizophrenia April 28, 2023 Read More »
FDA Approves Abilify Asimtufii® (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults April 28, 2023 Read More »
Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error April 27, 2023 Read More »